HSBC analyst Sidharth Sahoo raised the firm’s price target on Thermo Fisher to $670 from $660 and keeps a Buy rating on the shares. The analyst says leading indicators and management commentary are consistent and point towards a Q4 weighted recovery. The firm continues to believe that the life science tools market is set for a cyclical recovery and that Thermo is likely to return to a high-single-digit organic growth path from 2025 onwards.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMO:
- Thermo Fisher price target raised to $610 from $600 at Deutsche Bank
- Thermo Fisher price target raised to $662 from $657 at RBC Capital
- Thermo Fisher price target raised to $648 from $644 at TD Cowen
- Thermo Fisher price target raised to $650 from $600 at JPMorgan
- Thermo Fisher price target lowered to $620 from $621 at Baird
